We included all unique episodes of E. coli bacteremia from 2017 to 2020. A person could be included more than once during the four year study period, but all E. coli positive blood cultures within 7 days of an initial blood culture ...
E coli bacteremia requires at least seven days of antibiotics and identification of the source of bacteremia based on clinical examination, imaging studies as indicated, and laboratory analysis. Seven days of antibiotic treatment is non-inferior to 14 days (E Coli), however if the patient were ...
Antibiotic treatments have detrimental effects on the microbiome and lead to antibiotic resistance. To develop a phage therapy against a diverse range of clinically relevantEscherichia coli, we screened a library of 162 wild-type (WT) phages, identifying eight phages with broad coverage ofE. coli, ...
In our series, 81.6% episodes received appropriate initial antibiotic treatment and no significant decrease in it was found in bacteremia due to ESBL E coli and patients with neutropenia, septic shock. Septic shock was noted in 15.5% patients and the overall 30-day mortality rate was 21.7%. ...
coli serovar causing the infection to be tested to determine antibiotic susceptibilities. How is self-care at home done for enterovirulent E. coli? The majority of enterovirulent E. coli (EEC) infections are self-limited; they require no treatment except to keep the person well hydrated (oral...
[2] Tamma PD, Han JH, Rock C, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia [published correction appears in Clin Infect Dis. 2015 Jul 1;61(1):143]. Clin Infect Dis. 2015;60(...
Conway SP, Brownlee KG, Denton M, Peckham DG: Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Am J Respir Med. 2005, 2 (4): 321-32. Article Google Scholar Rehfuss M, Urban J: Alcaligenes faecalis subsp. phenolicus subsp. nov. a phenol-degrading, denitrifying bact...
[8] Lee NY, Lee CC, Huang WH, Tsui KC, Hsueh PR, Ko WC. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters. Clin Infect Dis. 2013;56(4):488-495. doi:10.1093/cid/cis916 ...
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Prophylactic treatment with fluoroquinolones of patients with profound neutropenia has been found to be useful for preventing gram-negative bacteremia and ... WV Kern,E Andriof,M Oethinger,... - 《Antimicrobial Agents & Chem...
The administration of appropriate antibiot- ics dependent upon susceptibility pattern is life-saving for the treatment of severe E. coli infections. However, the emergence of antibiotic-resistant E. coli has limited the therapeutic options available to physicians1,2. The production of β-lactamase...